The 17th Annual Conference of the International Society for the Study of Drug Policy will feature leading drug policy scholars and practitioners from across the globe.
Civil society, UN agencies and Member states will discuss key practicalities of ongoing processes at the heart of the Commission on Crime Prevention and Criminal Justice (CCPCJ) and the Commission on Narcotic Drugs (CND).
A recent OHCHR report underscores the vast human rights issues fueled by the drug war, encouraging member nations to transition away from punitive drug control measures in favor of a public health-centered approach.
EuroNPUD advocate for peer-led harm reduction delivered by, with and for people who use drugs and provide technical resources that support the delivery of peer-led harm reduction by drug user organisations and peer work projects.
Over 100 civil society groups worldwide urge the international community to listen to the UN Human Rights Chief's call for reforming global drug control regime and national drug laws.
Ann Fordham (IDPC Executive Director) analyses the key takeaways and significance of the OHCHR's latest report, noting how its call for transformative change includes an unprecedented recommendation to consider the responsible regulation of illegal drug markets.
Harm Reduction International identify key moments where drug policy will be addressed in the upcoming 54th Session of the Human Rights Council, presenting significant prospects for reform.
Harm Reduction International expose the large sums of aid being spent on drug prohibition worldwide, calling on governments and donors to divest from punitive policies and invest in health and human rights.
Huge amounts of aid have been spent on fuelling drug prohibition in lower-income countries, causing significant harm to vulnerable communities while defaulting on stated supply-reduction goals.
Persistent 'tough on drugs' approaches do not prevent drug use, they have only served as a tool of discrimination, harming police and community relations.
IDPC highlights the major gains from the 2023 OHCHR report on human rights and drug policy, and provides recommendations to Member States and UN entities for its effective implementation.
To better understand and document this growing legacy, consider avenues for further expansion, and strengthen learning tools, IDPC is looking for an experienced consultant to conduct an evaluation of the campaign’s lifetime.